| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5595872 | The American Journal of the Medical Sciences | 2017 | 17 Pages |
Abstract
HCV treatment regimens including interferon or ribavirin may precipitate PCT relapse. Hydroxychloroquine may be useful to prevent such relapses. In this limited experience, DAA were not associated with PCT relapse. Studies are needed to examine DAA as a primary PCT treatment in HCV-infected patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ashwani K. MD, MS, Krishna V.R. MD, Sarat MD, Fakhar-Ul MBBS, Karl E. MD,